General
Preferred name
TAZOMELINE
Synonyms
TAZOMELINE CITRATE ()
Tazomelina ()
LY-287041 ()
LY287041 ()
P&D ID
PD067034
CAS
131987-54-7
175615-45-9
Tags
available
drug candidate
Drug indication
Cognitive impairment
Drug Status
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
284
DESCRIPTION
Tazomeline is a muscarinic M1 receptor agonist with neuroprotective activity.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
5
ChEMBL Drugs
DrugMAP
DrugMatrix
ReFrame library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
19
Molecular Weight
297.13
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
0
Rotatable Bonds
7
Ring Count
2
Aromatic Ring Count
1
cLogP
3.93
TPSA
29.02
Fraction CSP3
0.71
Chiral centers
0.0
Largest ring
6.0
QED
0.56
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
muscarinic receptor
Pathway
Neuroscience
Source data
